# FDA Inspection 816527 - Tianjin Central Pharmaceutical Co., Ltd. - January 17, 2013

Source: https://www.keypedia.com/records/fda_inspections/tianjin-central-pharmaceutical-co-ltd/f4c8efc1-280e-4a19-a510-e71be9489dac
Source feed: FDA_Inspections

> FDA Inspection 816527 for Tianjin Central Pharmaceutical Co., Ltd. on January 17, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 816527
- Company Name: Tianjin Central Pharmaceutical Co., Ltd.
- Inspection Date: 2013-01-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1163357 - 2021-12-17](https://www.keypedia.com/records/fda_inspections/tianjin-central-pharmaceutical-co-ltd/3846f8cf-bd43-4596-96ef-50b5c78cf5f1)
- [FDA Inspection 1163357 - 2021-12-17](https://www.keypedia.com/records/fda_inspections/tianjin-central-pharmaceutical-co-ltd/0a8bad36-2817-4fe1-8e1d-3a61b1a81d10)
- [FDA Inspection 922889 - 2015-03-20](https://www.keypedia.com/records/fda_inspections/tianjin-central-pharmaceutical-co-ltd/75c45c5c-7022-4181-ac64-d959c432695f)
- [FDA Inspection 694808 - 2010-07-20](https://www.keypedia.com/records/fda_inspections/tianjin-central-pharmaceutical-co-ltd/316fa048-41cd-45c2-bd5a-3e2d6844be83)
- [FDA Inspection 694808 - 2010-07-20](https://www.keypedia.com/records/fda_inspections/tianjin-central-pharmaceutical-co-ltd/61151cdb-db8e-49e9-b21a-74b541c2ea01)

Company: https://www.keypedia.com/companies/tianjin-central-pharmaceutical-co-ltd/26c20286-f5d6-4612-8e6f-d7392fd08b82

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c